These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9791425)

  • 61. Disability and borderline personality symptoms.
    Sansone RA; Hruschka J; Vasudevan A; Miller SN
    Psychosomatics; 2003; 44(5):442. PubMed ID: 12954928
    [No Abstract]   [Full Text] [Related]  

  • 62. Modern tricyclic antidepressant drugs are hardly distinguishable in efficacy or safety for treatment of depressive mood disorders in controlled clinical trials.
    Glassman AH; Davis JM
    J Clin Psychopharmacol; 1993 Aug; 13(4):296-9. PubMed ID: 8376622
    [No Abstract]   [Full Text] [Related]  

  • 63. Advances with antidepressants; clinical experiences with mianserin.
    Montgomery SA
    Acta Psychiatr Scand Suppl; 1983; 302():90-4. PubMed ID: 6573111
    [No Abstract]   [Full Text] [Related]  

  • 64. The clinical relevance of preclinical data: mirtazapine, a model compound.
    Delbressine LP; Vos RM
    J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():29S-33S. PubMed ID: 9090575
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tricyclic antidepressant prescribing by psychiatrists and other physicians.
    Woster PS; Montgomery PA; Guthrie SK
    Am J Hosp Pharm; 1994 Feb; 51(3):381-4. PubMed ID: 8160693
    [No Abstract]   [Full Text] [Related]  

  • 66. Current knowledge of tricyclic antidepressant response indicators.
    Tilley DH; Goldberg SC; Friedel RO
    Psychopharmacol Bull; 1982 Oct; 18(4):132-5. PubMed ID: 7156276
    [No Abstract]   [Full Text] [Related]  

  • 67. 36-Year-old woman with loss of consciousness, fever, and tachycardia.
    Freeman WD; Chabolla DR
    Mayo Clin Proc; 2005 May; 80(5):667-70. PubMed ID: 15887435
    [No Abstract]   [Full Text] [Related]  

  • 68. [Antidepressant monotherapy: efficacy and tolerability of mianserin (Athymil)].
    Pringuey D; Yzombard G; Tatossian A
    Ann Med Psychol (Paris); 1981 Nov; 139(9):1003-14. PubMed ID: 7039459
    [No Abstract]   [Full Text] [Related]  

  • 69. Controversies in antidepressant therapy.
    Schatzberg AF
    J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):29-30. PubMed ID: 6630161
    [No Abstract]   [Full Text] [Related]  

  • 70. The effectiveness of 6-azamianserin (Org 3770) in depressed outpatients.
    Claghorn JL; Johnstone EE; Studebaker SL; Ajeman SA
    Psychopharmacol Bull; 1987; 23(1):160-1. PubMed ID: 3602313
    [No Abstract]   [Full Text] [Related]  

  • 71. Dexamethasone suppression and tricyclic antidepressant.
    Cliff G
    N Z Med J; 1982 Sep; 95(716):673. PubMed ID: 6957796
    [No Abstract]   [Full Text] [Related]  

  • 72. Tricyclic antidepressants: advantages and limitations.
    Geriatrics; 1993 Nov; 48 Suppl 2():6-8. PubMed ID: 8244042
    [No Abstract]   [Full Text] [Related]  

  • 73. Mirtazepine: heir apparent to amitriptyline?
    Davis MP; Dickerson ED; Pappagallo M; Benedetti C; Grauer PA; Lycan J
    Am J Hosp Palliat Care; 2001; 18(1):42-6. PubMed ID: 11406877
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial.
    Linden M; Westram A; Schmidt LG; Haag C
    Eur Psychiatry; 2008 Sep; 23(6):403-8. PubMed ID: 18583105
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Current management of depression.
    Kerr K; Johnson G
    Aust Fam Physician; 1986 Apr; 15(4):500-2. PubMed ID: 3718363
    [No Abstract]   [Full Text] [Related]  

  • 76. [Third-generation antidepressive agents. Experience with 100 cases of primary depression treated with viloxazine, nomifensine and mianserin].
    Faravelli C; Tonini R; Zaccara G; Marchetti G
    Minerva Psichiatr; 1981; 22(2):79-83. PubMed ID: 7266323
    [No Abstract]   [Full Text] [Related]  

  • 77. [Current therapeutic possibilities with tricyclic antidepressive agents].
    Nervenarzt; 1994 Aug; 65(8 Suppl):1-8. PubMed ID: 9211670
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharmacological prevention of suicidal behaviour.
    Montgomery SA; Montgomery D
    J Affect Disord; 1982 Dec; 4(4):291-8. PubMed ID: 6131083
    [No Abstract]   [Full Text] [Related]  

  • 79. [The safety of Tolvon].
    Hermans RB
    Ned Tijdschr Geneeskd; 1983 Nov; 127(48):2203. PubMed ID: 6656907
    [No Abstract]   [Full Text] [Related]  

  • 80. Tricyclic antidepressant drugs in the ambulatory treatment of depression.
    Gillette RD; Oxman TE
    J Fam Pract; 1983 Aug; 17(2):342-4. PubMed ID: 6875494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.